[go: up one dir, main page]

PL3682247T3 - Proadrenomedulina jako marker nieprawidłowych poziomów płytek krwi - Google Patents

Proadrenomedulina jako marker nieprawidłowych poziomów płytek krwi

Info

Publication number
PL3682247T3
PL3682247T3 PL18765659T PL18765659T PL3682247T3 PL 3682247 T3 PL3682247 T3 PL 3682247T3 PL 18765659 T PL18765659 T PL 18765659T PL 18765659 T PL18765659 T PL 18765659T PL 3682247 T3 PL3682247 T3 PL 3682247T3
Authority
PL
Poland
Prior art keywords
proadrenomedullin
marker
platelet levels
abnormal platelet
abnormal
Prior art date
Application number
PL18765659T
Other languages
English (en)
Inventor
Aline PEHLA
Stefan Kirsch
Darius Wilson
Original Assignee
B.R.A.H.M.S Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by B.R.A.H.M.S Gmbh filed Critical B.R.A.H.M.S Gmbh
Publication of PL3682247T3 publication Critical patent/PL3682247T3/pl

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/86Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood coagulating time or factors, or their receptors
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/22Haematology
    • G01N2800/222Platelet disorders
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/50Determining the risk of developing a disease
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/52Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
PL18765659T 2017-09-13 2018-09-13 Proadrenomedulina jako marker nieprawidłowych poziomów płytek krwi PL3682247T3 (pl)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
EP17190912 2017-09-13
EP18161091 2018-03-09
PCT/EP2018/074725 WO2019053118A1 (en) 2017-09-13 2018-09-13 PROADRÉNOMÉDULLINE AS A MARKER OF ABNORMAL PLATELET RATES
EP18765659.0A EP3682247B1 (en) 2017-09-13 2018-09-13 Proadrenomedullin as a marker for abnormal platelet levels

Publications (1)

Publication Number Publication Date
PL3682247T3 true PL3682247T3 (pl) 2022-04-25

Family

ID=63517904

Family Applications (1)

Application Number Title Priority Date Filing Date
PL18765659T PL3682247T3 (pl) 2017-09-13 2018-09-13 Proadrenomedulina jako marker nieprawidłowych poziomów płytek krwi

Country Status (8)

Country Link
US (3) US11327082B2 (pl)
EP (3) EP3971573A1 (pl)
JP (1) JP7346389B2 (pl)
CN (1) CN111094987B (pl)
DK (1) DK3682247T3 (pl)
ES (1) ES2909399T3 (pl)
PL (1) PL3682247T3 (pl)
WO (1) WO2019053118A1 (pl)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2022532947A (ja) * 2019-05-24 2022-07-20 アスチュート メディカル,インコーポレイテッド C-cモチーフケモカインリガンド14の測定に基づく腎損傷の評価および処置のための方法
CN114113580A (zh) * 2020-08-25 2022-03-01 张曼 尿液血栓调节蛋白及其多肽片段在烧伤中的应用
CN119780441A (zh) * 2024-12-25 2025-04-08 首都医科大学附属北京胸科医院 一种诊断近期及远期结核感染的生物标志物

Family Cites Families (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2570703B1 (fr) 1984-09-26 1988-07-08 Commissariat Energie Atomique Complexes macropolycycliques de terres rares et application a titre de marqueurs fluorescents
US4882733A (en) 1987-03-13 1989-11-21 Ford Aerospace Corporation Method and apparatus for combining encoding and modulation
FR2664699B1 (fr) 1990-07-13 1995-08-18 Cis Bio Int Procede d'amplification du signal d'emission d'un compose luminescent.
DE69602756T2 (de) 1995-08-18 2000-02-10 The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services, Rockville Funktionelle rolle von adrenomedullin(am) und dem gen-verwandten produkt(pamp) in der menschlichen pathologie und physiologie
DE19847690A1 (de) * 1998-10-15 2000-04-20 Brahms Diagnostica Gmbh Verfahren und Substanzen für die Diagnose und Therapie von Sepsis und sepsisähnlichen systemischen Infektionen
KR100425525B1 (ko) 2000-11-21 2004-03-30 재단법인서울대학교산학협력재단 조산과 태아감염 및 태아손상을 산전 진단하기 위한진단시약 및 진단키트
AU2002327649A1 (en) * 2001-09-19 2003-04-01 Mcmaster University Treatment of sepsis with tafi
DE10316583A1 (de) 2003-04-10 2004-10-28 B.R.A.H.M.S Aktiengesellschaft Bestimmung eines midregionalen Proadrenomedullin-Teilpeptids in biologischen Flüssigkeiten zu diagnostischen Zwecken, sowie Immunoassays für die Durchführung einer solchen Bestimmung
US20060029589A1 (en) * 2004-06-01 2006-02-09 Hartmut Weiler Induction of heterozygous FV Leiden carrier status to reduce mortality in sepsis and to prevent organ damage caused by inflammation and/or ischemia-reperfusion injury
CA2614507A1 (en) * 2004-07-09 2006-08-17 Amaox, Ltd. Immune cell biosensors and methods of using same
ES2300681T3 (es) * 2004-07-22 2008-06-16 Brahms Aktiengesellschaft Procedimiento para el diagnostico y tratamiento de pacientes criticos con endotelina, agonistas de endotelina y antagonistas de adrenomedulina.
US8906857B2 (en) * 2005-12-01 2014-12-09 B.R.A.H.M.S. Gmbh Methods for the diagnosis and treatment of critically ill patients with endothelin, endothelin agonists and adrenomedullin antagonists
WO2007067983A2 (en) * 2005-12-09 2007-06-14 Wyeth Sulfotyrosine specific antibodies and uses therefor
DE102006027818A1 (de) * 2006-06-16 2007-12-20 B.R.A.H.M.S. Aktiengesellschaft In vitro Multiparameter-Bestimmungsverfahren zur Diagnose und Frühdiagnose von neurodegenerativen Erkrankungen
DE102006034142A1 (de) 2006-07-24 2008-01-31 B.R.A.H.M.S. Aktiengesellschaft Verfahren zur Steuerung der Therapie von Patienten mit Herzinsuffizienz anhand der vitro Bestimmung von Schwellenwerten von vasoaktiven Peptiden
DE102006052916A1 (de) * 2006-11-08 2008-05-15 Brahms Aktiengesellschaft Diagnose und Risikostratifizierung von Diabetes mellitus mittels MR-proADM
US9012151B2 (en) * 2006-11-09 2015-04-21 B.R.A.H.M.S. Gmbh Methods of diagnosis and risk stratification of adverse events in post myocardial infarction patients using pro-adrenomedullin
DE102006060112A1 (de) 2006-12-20 2008-06-26 Brahms Aktiengesellschaft Diagnose und Risikostratifizierung mittels dem neuen Marker CT-proADM
EP2118665B1 (en) 2007-03-12 2012-04-18 Biomedica Medizinprodukte GmbH & Co KG Diagnosis of septic complications
CN101796418B (zh) 2007-09-07 2013-05-01 苏黎世大学 检测分析人体脓毒症的方法
MX2010004615A (es) * 2007-10-26 2010-07-06 Oklahoma Med Res Found Anticuerpos monoclonales contra proteina c. activada e inactivada.
WO2009062948A1 (en) 2007-11-16 2009-05-22 Pronota N.V. Biomarkers and methods for diagnosing, predicting and/or prognosing sepsis and uses thereof
ES2643033T3 (es) 2009-05-05 2017-11-21 B.R.A.H.M.S Gmbh Estratificación basada en la hormona vasoactiva de los pacientes que sufren de enfermedades relacionadas con la función/disfunción endotelial
ITPI20090066A1 (it) * 2009-05-26 2010-11-27 Consiglio Nazionale Ricerche Metodo per produrre un dispositivo applicabile a tessuti biologici, in particolare un patch per trattare tessuti danneggiati, e dispositivo ottenuto con tale metodo
JP5731489B2 (ja) 2009-06-05 2015-06-10 ベー.エル.アー.ハー.エム.エス ゲゼルシャフト ミット ベシュレンクテル ハフツング 呼吸困難を起こした患者における細菌感染の検出
EP2494865A4 (en) * 2009-09-01 2014-05-14 Aeon Medix Inc EXTRACELLULAR VESICLES OBTAINED FROM THE DARMFLORA, AND METHOD FOR SEARCHING FOR A DISEASE MODEL, VACCINE AND CANDIDATE AND DIAGNOSTIC METHOD THEREFOR
JP5722587B2 (ja) 2009-10-13 2015-05-20 ベー.エル.アー.ハー.エム.エス ゲゼルシャフト ミット ベシュレンクテル ハフツング 急性脳卒中または一過性脳虚血発作を有する患者における細菌感染の診断のためのプロカルシトニン及び抗生物質治療のガイダンス
CN102822675B (zh) 2010-03-08 2016-06-01 B.R.A.H.M.S有限公司 降钙素原用于在具有非特异性不适的患者中诊断细菌感染和指导抗生素治疗
RU2618437C2 (ru) 2010-11-01 2017-05-03 Б.Р.А.Х.М.С Гмбх Оценка прогноза и риска пациентов с неспецифическими жалобами
PT2781221T (pt) * 2011-11-15 2020-06-01 Asahi Kasei Pharma Corp Medicamento para tratamento e/ou melhoria de sepsia
HRP20170427T1 (hr) * 2011-11-16 2017-06-16 Sphingotec Gmbh Testovi na adrenomedulin i postupci određivanja zrelog adrenomedulina
EP3540440B1 (en) 2011-12-08 2022-09-28 Astute Medical, Inc. Methods and uses for evaluating renal injury and renal status
EP2657707A1 (en) * 2012-04-26 2013-10-30 B.R.A.H.M.S GmbH Biomakers for the diagnosis, prognosis, assessment and therapy stratification syncope
ES2755623T3 (es) * 2012-05-07 2020-04-23 Lsi Medience Corp Procedimiento de detección de coagulación intravascular diseminada o coagulación intravascular diseminada infecciosa
WO2014147153A1 (en) 2013-03-20 2014-09-25 Sphingotec Gmbh Adrenomedullin to guide therapy of blood pressure decline
WO2015147369A1 (ko) * 2014-03-27 2015-10-01 전북대학교산학협력단 Sirt2 억제제를 포함하는 약학적 조성물
HK1256104A1 (zh) 2015-11-27 2019-09-13 B.R.A.H.M.S Gmbh 作为对象的细胞外容量状态的标志物的mr-proadm
MX2019000003A (es) 2016-07-08 2019-08-29 Sphingotec Gmbh Adrenomodulina para evaluar la congestión en un individuo con insuficiencia cardiaca aguda.
JP7104689B2 (ja) 2016-08-09 2022-07-21 ベー.エル.アー.ハー.エム.エス ゲゼルシャフト ミット ベシュレンクテル ハフツング 有害事象を示すマーカーとしてのヒストンおよび/またはproADM

Also Published As

Publication number Publication date
US12000845B2 (en) 2024-06-04
US20200271675A1 (en) 2020-08-27
CN111094987A (zh) 2020-05-01
JP2020533593A (ja) 2020-11-19
EP3682247A1 (en) 2020-07-22
CN111094987B (zh) 2023-10-31
EP3971573A1 (en) 2022-03-23
JP7346389B2 (ja) 2023-09-19
US12405279B2 (en) 2025-09-02
EP3682247B1 (en) 2022-02-09
ES2909399T3 (es) 2022-05-06
WO2019053118A1 (en) 2019-03-21
EP3971572A1 (en) 2022-03-23
US11327082B2 (en) 2022-05-10
US20220229076A1 (en) 2022-07-21
US20220221474A1 (en) 2022-07-14
DK3682247T3 (da) 2022-03-21

Similar Documents

Publication Publication Date Title
ZA201803213B (en) A health-monitor patch
ZA201802206B (en) Beam-scan time indicator
GB2540343B (en) A reusable cup
GB2545496B (en) A Test System
PT3303567T (pt) Processo de esterilização de um lisado plaquetário
IL255108A0 (en) Essay
GB201519623D0 (en) A platform
GB201514915D0 (en) A karabiner
PL3337928T3 (pl) Urządzenie do ukształtowania przejazdu kolejowego
PL3682247T3 (pl) Proadrenomedulina jako marker nieprawidłowych poziomów płytek krwi
GB2560395B (en) A programmable audio level indicator
GB201513569D0 (en) A carton
SG10201504761YA (en) Composition for Markings
GB2569272B (en) Direction indicator
IL256047A (en) A primer for pesticides
GB201521798D0 (en) A fuse
GB201522749D0 (en) A pH indicator composition
GB2542945B (en) A carton
PL3278644T3 (pl) Stabilizator cięgła dolnego podnośnika
GB2579752B (en) A test system
PL3389356T3 (pl) Mechanizm zatrzymujący do maszyny rolniczej
GB2538781B (en) A beam
GB2558110B (en) A Carton
GB201618172D0 (en) Assembly for a game
GB201619771D0 (en) Indicator